ACHV

Conviction 100HealthcareScan · Mon, Aug 10, 2026

ACHV$6.66+0.15%

ResistanceSupportVol 14

Vol MA14 1.29M

May 11May 28Jun 16Jul 6Jul 23Aug 10

ACHIEVE LIFE SCIENCES, INC.IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCESwww.achievelifesciences.com ↗

Price6.66

Change+0.15%

Gap-0.60%

Rel volume5.06×

Avg volume1.32M

Avg $ vol8.4M

SMA 206.34

SMA 505.95

SMA 2004.85

Price vs 50+11.98%

Price vs 200+37.28%

MA stackbullish

50/200 cross—

Supertrendup · 5.71

RSI (14)62

MACD hist0.01

MACD crossbull · 3d

Stoch %K / %D84 / 82

ADX (14)19

+DI / −DI18 / 10

RSI divergence—

MACD divergence—

ATR %+5.27%

ADR %5.61%

52w high6.66

52w low2.44

From 52w high+0.00%

Above 52w low+172.95%

New 52w highYes

SqueezeOn · 13d

Bollinger width11.99%

%B0.92

Donchian pos86.54%

Donchian high6.80

Donchian low5.76

AVWAP (52w high)6.36

vs AVWAP high+4.72%

AVWAP (52w low)4.70

vs AVWAP low+41.60%

OBV trendUp

Chaikin MF (20)0.04

Today vs 20d5.06×

Avg vol (14d)1.29M

Avg vol (20d)1.32M

Avg $ vol (20d)8.4M

Market cap683.71M

RS 3m (vs SPY)+33.13%

RS 6m (vs SPY)+54.24%

RS line new highNo

Trend template8/8

Technical rank86.9

1 week+5.38%

1 month+9.00%

3 months+27.83%

6 months+56.71%

1 year+152.27%

YTD+34.00%

P/E-12.51

P/B64.03

P/S—

P/FCF-13.82

EPS-1.25

Div yield—

ROE-511.78%

ROA-165.07%

Debt/Eq—

Current2.62

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-37.21%

Price target14.71

Target upside120.87%

Analyst ratingBuy

Institutional31.72%

Ent. value655.63M

Revenue—

Net income-10.17M

Gross profit—

Free cash flow-49.47M

IndustryIN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

ExchangeNasdaq

Shares out102.66M

Employees28

ListedThu, Oct 12, 1995

Free float39.1M

Float %73.5%

Short interest14.73M

Days to cover7.8d

Short volume50.6%

Squeeze score87 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.19 vs −$0.30

Last surprise+36.7% beat

Setup gradeA+

Conviction100 / 100

Pattern quality—

Tech rank86.9 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.87

Support5.29

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ACHV

All disclosures →

No recent disclosed trades by Congress in ACHV. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ACHV · 6 buys

Insider	Side	Shares	Value	Traded	Filed
Waldman Reid Alexander Director · Stock Option (right to buy) · 2026-05-29	Grant	47.25K	$0	2026-05-29	2026-06-02
Farrow Jeffrey S Director · Stock Option (right to buy) · 2026-05-29	Grant	47.25K	$0	2026-05-29	2026-06-02
Martin Christopher Nathan Director · Stock Option (right to buy) · 2026-05-11	Grant	47.25K	$0	2026-05-11	2026-05-13
Goldberg Andrew D. CEO and President · Performance Restricted Stock Unit (PRSU) · 2026-04-18	Grant	11.71M	$0	2026-04-18	2026-04-21
Goldberg Andrew D. CEO and President · Restricted Stock Unit (RSU) · 2026-04-18	Grant	1.8M	$0	2026-04-18	2026-04-21
Goldberg Andrew D. CEO and President · Stock Option (right to buy) · 2026-04-18	Grant	3.6M	$0	2026-04-18	2026-04-21

SEC filings

EDGAR filings in ACHV · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.